Abstract:Hypertension (HTN) is a major contributor to kidney damage, leading to conditions such as nephrosclerosis and hypertensive nephropathy, significant causes of chronic kidney disease (CKD) and end-stage renal disease (ESRD). HTN is also a risk factor for stroke and coronary heart disease. Oxidative stress, inflammation, and activation of the renin–angiotensin–aldosterone system (RAAS) play critical roles in causing kidney injury in HTN. Genetic and environmental factors influence the susceptibility to hypertensive renal damage, with African American populations having a higher tendency due to genetic variants. Managing blood pressure (BP) effectively with treatments targeting RAAS activation, oxidative stress, and inflammation is crucial in preventing renal damage and the progression of HTN-related CKD and ESRD. Interactions between genetic and environmental factors impacting kidney function abnormalities are central to HTN development. Animal studies indicate that genetic factors significantly influence BP regulation. Anti-natriuretic mechanisms can reset the pressure–natriuresis relationship, requiring a higher BP to excrete sodium matched to intake. Activation of intrarenal angiotensin II receptors contributes to sodium retention and high BP. In HTN, the gut microbiome can affect BP by influencing energy metabolism and inflammatory pathways. Animal models, such as the spontaneously hypertensive rat and the chronic angiotensin II infusion model, mirror human essential hypertension and highlight the significance of the kidney in HTN pathogenesis. Overproduction of reactive oxygen species (ROS) plays a crucial role in the development and progression of HTN, impacting renal function and BP regulation. Targeting specific NADPH oxidase (NOX) isoforms to inhibit ROS production and enhance antioxidant mechanisms may improve renal structure and function while lowering blood pressure. Therapies like SGLT2 inhibitors and mineralocorticoid receptor antagonists have shown promise in reducing oxidative stress, inflammation, and RAAS activity, offering renal and antihypertensive protection in managing HTN and CKD. This review emphasizes the critical role of NOX in the development and progression of HTN, focusing on its impact on renal function and BP regulation. Effective BP management and targeting oxidative stress, inflammation, and RAAS activation, is crucial in preventing renal damage and the progression of HTN-related CKD and ESRD.

Primary Role of the Kidney in Pathogenesis of Hypertension

The Role of the Kidney in Hypertension

Oxidative Stress in Kidney Injury and Hypertension

Single-nucleus Sequencing Reveals Endothelial Cell-specific Dysregulation in the Kidney in Multiple Models of Hypertension

Genetic Susceptibility of Hypertension‐induced Kidney Disease

Kidney Ion Handling Genes and Their Interaction in Blood Pressure Control

Key Players in Hypertensive Renovascular Damage

The Pathogenesis of Hypertension in Autosomal Dominant Polycystic Kidney Disease

Hypertension in chronic kidney disease: What lies behind the scene

Sympathetic overactivity as a cause of hypertension in chronic renal failure

Pressure natriuresis and the renal control of arterial blood pressure

Myriad of factors involved in blood pressure control. Salt intake connects them all

Renal Metabolism and Hypertension

[Long-Term Regulation of Arterial Pressure and Essential Hypertension--ii. Essential Hypertension].

The crosstalk between the kidney and the central nervous system: the role of renal nerves in blood pressure regulation

Elevated Endothelial Hypoxia-Inducible Factor-1α Contributes to Glomerular Injury and Promotes Hypertensive Chronic Kidney Disease.

Kidney microbiota dysbiosis contributes to the development of hypertension

Signaling Mechanisms That Link Salt Retention to Hypertension: Endogenous Ouabain, the Na+ Pump, the Na+/Ca2+ Exchanger and TRPC Proteins

Angiotensin II and AT1a Receptors in the Proximal Tubules of the Kidney: New Roles in Blood Pressure Control and Hypertension

Role of the Sympathetic Nervous System and Its Modulation in Renal Hypertension